What is NDC 60429-643?

60429-643 is the product NDC for Ibandronate Sodium, Ibandronate sodium 150 mg/1 tablet, film coated, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Golden State Medical Supply, Inc., NDC labeler code 60429. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ibandronate Sodium?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ibandronate Sodium NDC 60429-643 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60429-643Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60429-0643Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60429-643-73	60429064373	3 BLISTER PACK in 1 PACKAGE (60429-643-73) / 1 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Feb 5, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ibandronate Sodium
Generic name (nonproprietary): ibandronate sodium
Active ingredients: Ibandronate sodium — 150 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Golden State Medical Supply, Inc.NDC labeler code 60429
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078948
Marketing start: Mar 19, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Diphosphonates (Chemical structure)
Identifiers: Product ID 60429-643_4b35c1c6-29e6-40f7-e063-6294a90ada88SPL ID 4b35c1c6-29e6-40f7-e063-6294a90ada88SPL set ID 618e1aff-ccbb-4cee-93f1-fe04e33dacb7RxCUI 904932UNII J12U072QL0
Pharmacologic class: Bisphosphonate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460429064373 followed by a unit qualifier and the quantity

Package 60429-0643-73. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 19, 2026.

Indications (excerpt from the label)

Ibandronate sodium tablet is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis. ( 1.1 ). Limitations of Use The optimal duration of use has not been determined. For patients at low -risk for fracture, consider drug discontinuation after 3 to 5 years of use. ( 1.2 ). 1.1 Treatment and Prevention of Postmenopausal Osteoporosis Ibandronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. Ibandronate sodium increases bone mineral density (BMD) and reduces the incidence of vertebral fractures. 1.2 Important Limitations of Use Theoptimalduration of use has not been determined. The safety and effectivenes…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60429-643

What is NDC 60429-643?: 60429-643 is the product NDC for Ibandronate Sodium, Ibandronate sodium 150 mg/1 tablet, film coated, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ibandronate Sodium.
What is the active ingredient?: Ibandronate sodium.
Who is the labeler?: Golden State Medical Supply, Inc., NDC labeler code 60429. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ibandronate Sodium?: 7 other product NDCs are listed under this name. See all Ibandronate Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ibandronate Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ibandronate Sodium	Ibandronate sodium 150 mg/1	TabletOral	Bionpharma Inc.	69452-378	69452-0378-74
Ibandronate Sodium	Ibandronate sodium 150 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-150	33342-0150-5233342-0150-53
Ibandronate Sodium	Ibandronate sodium 3 mg/3mL	InjectionIntravenous	Apotex Corp.	60505-6097	60505-6097-00
Ibandronate Sodium	Ibandronate sodium 3 mg/3mL	Injection, SolutionIntravenous	Eugia US LLC	55150-191	55150-0191-83
Ibandronate Sodium	Ibandronate sodium 3 mg/3mL	Injection, SolutionIntravenous	Sun Pharmaceutical Industries, Inc.	62756-218	62756-0218-40
Ibandronate sodium	Ibandronate sodium 150 mg/1	TabletOral	A-S Medication Solutions	50090-7654	50090-7654-00
Ibandronate sodium	Ibandronate sodium 150 mg/1	TabletOral	Dr. Reddy's Laboratories Limited	55111-575	55111-0575-0355111-0575-43